AIF1 and central nervous system cancer: In Gli36ΔEGFR-2 generated glioma, TMZ+MET significantly reduced infiltration of Iba1 positive myeloid cells only at the tumor-brain border compared to TMZ (p = 0.005 versus TMZ, Figure 3G).